WallStSmart

IONQ Inc (IONQ)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 99% more annual revenue ($258.90M vs $130.02M). IONQ leads profitability with a 0.0% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 38/100 (F).

IONQ

Avoid

34

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 7.0
Piotroski: 4/9Altman Z: -2.58

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for IONQ.

ZEPPUndervalued (+48.9%)

Margin of Safety

+48.9%

Fair Value

$46.96

Current Price

$18.01

$28.95 discount

UndervaluedFair: $46.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IONQ2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
428.5%10/10

Revenue surging 428.5% year-over-year

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

IONQ4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-24.4%2/10

ROE of -24.4% — below average capital efficiency

Free Cash FlowQuality
$-83.30M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.3/10
Market CapQuality
$270.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Free Cash FlowQuality
$-26.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : IONQ

The strongest argument for IONQ centers on Revenue Growth, Debt/Equity. Revenue growth of 428.5% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : IONQ

The primary concerns for IONQ are EPS Growth, Profit Margin, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

IONQ carries more volatility with a beta of 2.80 — expect wider price swings.

IONQ is growing revenue faster at 428.5% — sustainability is the question.

ZEPP generates stronger free cash flow (-26M), providing more financial flexibility.

Monitor COMPUTER HARDWARE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (38/100 vs 34/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

IONQ Inc

TECHNOLOGY · COMPUTER HARDWARE · USA

IONQ Inc. is a pioneer in the quantum computing landscape, specializing in the development of advanced quantum processors and software solutions designed to address intricate computational challenges across diverse sectors. Established in 2015, the company has leveraged a cloud-based platform to make quantum technology more accessible, aiming to transform industries such as finance, logistics, and pharmaceuticals. With a robust portfolio of intellectual property and key strategic partnerships, IONQ is well-positioned to meet the growing demand for quantum applications, presenting a compelling opportunity for institutional investors interested in the next frontier of technological innovation.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?